821 related articles for article (PubMed ID: 18695366)
1. Current management of thrombotic thrombocytopenic purpura.
Kremer Hovinga JA; Meyer SC
Curr Opin Hematol; 2008 Sep; 15(5):445-50. PubMed ID: 18695366
[TBL] [Abstract][Full Text] [Related]
2. A case of severe ADAMTS13 deficiency presenting as thrombotic thrombocytopenic purpura in pregnancy.
Nikolaou M; Karakantza M; Adonakis G; Theodorou G; Zoumbos N; Decavalas G
Med Pregl; 2012; 65(9-10):436-9. PubMed ID: 23214340
[TBL] [Abstract][Full Text] [Related]
3. Current management and therapeutical perspectives in thrombotic thrombocytopenic purpura.
Coppo P; Veyradier A
Presse Med; 2012 Mar; 41(3 Pt 2):e163-76. PubMed ID: 22265954
[TBL] [Abstract][Full Text] [Related]
4. An update on the pathogenesis and management of acquired thrombotic thrombocytopenic purpura.
Yarranton H; Machin SJ
Curr Opin Neurol; 2003 Jun; 16(3):367-73. PubMed ID: 12858075
[TBL] [Abstract][Full Text] [Related]
5. Child-onset and adolescent-onset acquired thrombotic thrombocytopenic purpura with severe ADAMTS13 deficiency: a cohort study of the French national registry for thrombotic microangiopathy.
Joly BS; Stepanian A; Leblanc T; Hajage D; Chambost H; Harambat J; Fouyssac F; Guigonis V; Leverger G; Ulinski T; Kwon T; Loirat C; Coppo P; Veyradier A;
Lancet Haematol; 2016 Nov; 3(11):e537-e546. PubMed ID: 27720178
[TBL] [Abstract][Full Text] [Related]
6. ADAMTS13 and anti-ADAMTS13 antibodies as markers for recurrence of acquired thrombotic thrombocytopenic purpura during remission.
Peyvandi F; Lavoretano S; Palla R; Feys HB; Vanhoorelbeke K; Battaglioli T; Valsecchi C; Canciani MT; Fabris F; Zver S; Réti M; Mikovic D; Karimi M; Giuffrida G; Laurenti L; Mannucci PM
Haematologica; 2008 Feb; 93(2):232-9. PubMed ID: 18223285
[TBL] [Abstract][Full Text] [Related]
7. Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura.
Sadler JE
Blood; 2008 Jul; 112(1):11-8. PubMed ID: 18574040
[TBL] [Abstract][Full Text] [Related]
8. Thrombotic thrombocytopenic purpura in children.
Loirat C; Coppo P; Veyradier A
Curr Opin Pediatr; 2013 Apr; 25(2):216-24. PubMed ID: 23422353
[TBL] [Abstract][Full Text] [Related]
9. Treatment of thrombotic thrombocytopenic purpura beyond therapeutic plasma exchange.
Coppo P; Froissart A;
Hematology Am Soc Hematol Educ Program; 2015; 2015():637-43. PubMed ID: 26637782
[TBL] [Abstract][Full Text] [Related]
10. Treatment of thrombotic thrombocytopenic purpura.
Fontana S; Kremer Hovinga JA; Lämmle B; Mansouri Taleghani B
Vox Sang; 2006 May; 90(4):245-54. PubMed ID: 16635066
[TBL] [Abstract][Full Text] [Related]
11. Intravenous immunoglobulin as an adjunct to plasma exchange for the treatment of chronic thrombotic thrombocytopenic purpura.
Moore JC; Arnold DM; Leber BF; Clare R; Molnar GJ; Kelton JG
Vox Sang; 2007 Aug; 93(2):173-5. PubMed ID: 17683362
[TBL] [Abstract][Full Text] [Related]
12. Rituximab and intermediate-purity plasma-derived factor VIII concentrate (Koate®) as adjuncts to therapeutic plasma exchange for thrombotic thrombocytopenic purpura in patients with an ADAMTS13 inhibitor.
Pandey S; Nakagawa M; Rosenbaum ER; Arnaoutakis K; Hutchins LF; Makhoul I; Milojkovic N; Cottler-Fox M
J Clin Apher; 2015 Feb; 30(1):50-4. PubMed ID: 25042026
[TBL] [Abstract][Full Text] [Related]
13. [Successful treatment with rituximab in a patient with refractory thrombotic thrombocytopenic purpura refractory to plasma exchange].
Koshino M; Kudou D; Okoshi Y; Obara N; Simizu S; Mukai HY; Suzukawa K; Hasegawa Y; Kojima H; Nagasawa T; Chiba S
Rinsho Ketsueki; 2010 Feb; 51(2):127-31. PubMed ID: 20379104
[TBL] [Abstract][Full Text] [Related]
14. Recent advances in thrombotic thrombocytopenic purpura.
Sadler JE; Moake JL; Miyata T; George JN
Hematology Am Soc Hematol Educ Program; 2004; ():407-23. PubMed ID: 15561695
[TBL] [Abstract][Full Text] [Related]
15. Targeting the inhibitor of ADAMTS13 in thrombotic thrombocytopenic purpura.
Cataland SR; Wu HM
Expert Opin Pharmacother; 2007 Mar; 8(4):437-44. PubMed ID: 17309338
[TBL] [Abstract][Full Text] [Related]
16. Thrombotic thrombocytopenic purpura--the role of ADAMTS13 assay in clinical practice.
Duraković N; Radonić R; Gasparović V
Coll Antropol; 2010 Sep; 34(3):1087-91. PubMed ID: 20977108
[TBL] [Abstract][Full Text] [Related]
17. Current insight into thrombotic thrombocytopenic purpura.
Verbeke L; Delforge M; Dierickx D
Blood Coagul Fibrinolysis; 2010 Jan; 21(1):3-10. PubMed ID: 19851089
[TBL] [Abstract][Full Text] [Related]
18. Immunotherapy for thrombotic thrombocytopenic purpura.
Cataland SR; Wu HM
Curr Opin Hematol; 2005 Sep; 12(5):359-63. PubMed ID: 16093780
[TBL] [Abstract][Full Text] [Related]
19. Management of thrombotic thrombocytopenic purpura.
Coppo P;
Transfus Clin Biol; 2017 Sep; 24(3):148-153. PubMed ID: 28645643
[TBL] [Abstract][Full Text] [Related]
20. Thrombotic thrombocytopenic purpura: a moving target.
Sadler JE
Hematology Am Soc Hematol Educ Program; 2006; ():415-20. PubMed ID: 17124092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]